Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Exjade 360mg tablets
0901030K0BBAFAF
|
Exjade | Deferasirox | Nutrition and Blood | 4 |
|
Exjade 180mg tablets
0901030K0BBAEAE
|
Exjade | Deferasirox | Nutrition and Blood | 1 |
|
Exjade 90mg tablets
0901030K0BBADAD
|
Exjade | Deferasirox | Nutrition and Blood | 1 |
|
Exjade 125mg dispersible tablets
0901030K0BBAAAA
|
Exjade | Deferasirox | Nutrition and Blood | No data available |
|
Exjade 250mg dispersible tablets
0901030K0BBABAB
|
Exjade | Deferasirox | Nutrition and Blood | No data available |
|
Exjade 500mg dispersible tablets
0901030K0BBACAC
|
Exjade | Deferasirox | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.